Modernizing Medicine is the developer of healthcare specialty-specific platforms designed to help clients increase practice efficiency and focus on patient outcomes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/10/2017 | Series F | $235.96MM | $xx.xx | $96.21B | Warburg Pincus | |
Price per Share
$xx.xx
Shares Outstanding
225,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Warburg Pincus
|
||||||
09/21/2015 | Series E | $53.06MM | $xx.xx | $43.52B | Pentland Brands, Sands Capital Ventures, Summit Partners | |
Price per Share
$xx.xx
Shares Outstanding
94,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Pentland Brands, Sands Capital Ventures, Summit Partners
|
||||||
03/19/2015 | Series D | $20MM | $xx.xx | $32B | Ibm | |
Price per Share
$xx.xx
Shares Outstanding
40,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ibm
|
||||||
08/20/2013 | Series C | $14MM | $xx.xx | $18.13B | Summit Partners | |
Price per Share
$xx.xx
Shares Outstanding
46,323,779
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Summit Partners
|
||||||
07/17/2012 | Series B | $8.11MM | $xx.xx | $8.89B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
49,623,490
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
02/28/2011 | Series A | $5.45MM | $xx.xx | $4.27B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
78,476,370
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|